<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee SG</submitter><funding>Ministry of Trade, Industry and Energy</funding><pagination>e327</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12708972</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>40(48)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The skin microbiome plays a crucial role in defending against pathogens and modulating immunity, and its dysregulation is linked to various skin conditions, including acne.&lt;h4>Methods&lt;/h4>In this study, four previously identified strains-&lt;i>Staphylococcus epidermidis&lt;/i> B424F-5, &lt;i>S. epidermidis&lt;/i> BS47C-1, &lt;i>Dermacoccus profundi&lt;/i> BS35F-3, and &lt;i>Streptococcus salivarius&lt;/i> BS320F-4- were selected from a skin microbiome database of healthy individuals. The efficacy and safety of these strains against acne-related inflammation were evaluated using in vitro and in vivo animal model experiments.&lt;h4>Results&lt;/h4>&lt;i>Cutibacterium acnes&lt;/i> exposure increased the expression of acne-associated inflammatory mediators-such as IL-1β, IL-6, IL-8, COX-2, iNOS, and TNF-α-parti</pubmed_abstract><journal>Journal of Korean medical science</journal><pubmed_title>Efficacy and Safety of Human Skin Microbiome-Derived Strains as Topical Treatment for Acne: An In Vitro and In Vivo Study.</pubmed_title><pmcid>PMC12708972</pmcid><funding_grant_id>20024192</funding_grant_id><pubmed_authors>Ham S</pubmed_authors><pubmed_authors>Lee SG</pubmed_authors><pubmed_authors>Baek Y</pubmed_authors><pubmed_authors>Lee YI</pubmed_authors><pubmed_authors>Chu J</pubmed_authors><pubmed_authors>Kim KH</pubmed_authors><pubmed_authors>Shin CH</pubmed_authors><pubmed_authors>Lee JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Efficacy and Safety of Human Skin Microbiome-Derived Strains as Topical Treatment for Acne: An In Vitro and In Vivo Study.</name><description>&lt;h4>Background&lt;/h4>The skin microbiome plays a crucial role in defending against pathogens and modulating immunity, and its dysregulation is linked to various skin conditions, including acne.&lt;h4>Methods&lt;/h4>In this study, four previously identified strains-&lt;i>Staphylococcus epidermidis&lt;/i> B424F-5, &lt;i>S. epidermidis&lt;/i> BS47C-1, &lt;i>Dermacoccus profundi&lt;/i> BS35F-3, and &lt;i>Streptococcus salivarius&lt;/i> BS320F-4- were selected from a skin microbiome database of healthy individuals. The efficacy and safety of these strains against acne-related inflammation were evaluated using in vitro and in vivo animal model experiments.&lt;h4>Results&lt;/h4>&lt;i>Cutibacterium acnes&lt;/i> exposure increased the expression of acne-associated inflammatory mediators-such as IL-1β, IL-6, IL-8, COX-2, iNOS, and TNF-α-parti</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-06-06T03:57:05.563Z</modification><creation>2026-05-25T03:12:06.069Z</creation></dates><accession>S-EPMC12708972</accession><cross_references><pubmed>41399266</pubmed><doi>10.3346/jkms.2025.40.e327</doi></cross_references></HashMap>